Efficacy Of Lenalidomide In Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts And An Extreme Platelet Count

CLINICAL CASE REPORTS(2020)

引用 3|浏览14
暂无评分
摘要
Lenalidomide is efficient in reducing red blood cell transfusion dependency and markedly lowering platelet counts in MDS/MPN-RS-T in the context of major platelet counts.
更多
查看译文
关键词
lenalidomide, myelodysplastic syndrome, myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombosis, myeloproliferative syndrome, thrombocytosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要